MaxCyte Net Income Per Share from 2010 to 2026
| MXCT Stock | USD 0.80 -0.01 -1.23% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -0.35 | Current Value -0.37 | Quarterly Volatility 0.36392638 |
Macro event markers
The evolution of Net Income Per Share for MaxCyte provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how MaxCyte compares to historical norms and industry peers.
Latest MaxCyte's Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of MaxCyte over the last few years. It is MaxCyte's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MaxCyte's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
MaxCyte Net Income Per Share Regression Statistics
| Arithmetic Mean | -0.27 | |
| Coefficient Of Variation | -135.01 | |
| Mean Deviation | 0.20 | |
| Median | -0.20 | |
| Standard Deviation | 0.36 | |
| Sample Variance | 0.13 | |
| Range | 1.5711 | |
| R-Value | -0.13 | |
| Mean Square Error | 0.14 | |
| R-Squared | 0.02 | |
| Significance | 0.62 | |
| Slope | -0.01 | |
| Total Sum of Squares | 2.12 |
MaxCyte Net Income Per Share History
Methodology, Assumptions & Data Sources
MaxCyte's Net Income Per Share reference series captures how this indicator has evolved through different market cycles. Period-over-period changes can highlight acceleration or deceleration in this metric.
For MaxCyte, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Intraday timing differences may exist. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.